Related Experiment Videos

DNA damage/repair studies using a combination of monoclonal thymidine antibody and unscheduled DNA synthesis

N Soni1, I Mehdi, L Motyka

  • 1Roswell Park Memorial Institute, Department of Hematologic Oncology, Buffalo, NY.

Anticancer Research
|July 1, 1989
PubMed

Insights

A new antibody (MoAb 20B7) effectively detects chemotherapy-induced DNA damage by identifying exposed thymidine. This method allows simultaneous assessment of DNA repair, aiding cancer treatment research.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Biochemistry

Background:

  • Chemotherapy can induce DNA damage, necessitating methods to detect and assess repair.
  • Single-stranded DNA breaks are a key indicator of such damage.
  • Monoclonal antibodies offer specific detection tools for molecular targets.

Purpose of the Study:

  • To evaluate the efficacy of a novel monoclonal antibody (MoAb 20B7) against thymidine.
  • To determine if MoAb 20B7 can detect chemotherapy-induced single-stranded DNA damage.
  • To explore the combination of MoAb 20B7 detection with DNA repair assessment.

Main Methods:

  • Utilized HL-60 cells exposed to alkylating agents to induce DNA damage.
  • Applied MoAb 20B7 for the detection of exposed thymidine in damaged DNA segments.
  • Combined MoAb 20B7 detection with autoradiographic assessment of unscheduled DNA synthesis.

Main Results:

  • MoAb 20B7 consistently detected chemotherapy-induced single-stranded DNA damage.
  • The antibody successfully identified damaged DNA segments after endonuclease cleavage.
  • The integrated method allowed for simultaneous evaluation of DNA damage and repair.

Conclusions:

  • MoAb 20B7 is a reliable tool for detecting chemotherapy-induced DNA damage.
  • This antibody facilitates the study of DNA damage and repair mechanisms.
  • The combined approach offers a comprehensive method for evaluating cellular responses to chemotherapy.

Related Concept Videos